Sean Reilly, DAIC Publisher

Sean Reilly is healthcare brands group publisher (Imaging Technology News and Diagnostic and Interventional Cardiology) at Scranton Gillette Communications.
 

Blog | Sean Reilly, DAIC Publisher | January 09, 2013

Innovation Exasperation

In a recent LinkedIn Medical Device Group posting, it was noted that DuVal & Associates, P.A. filed a Citizen Petition and Petition for Stay of Action with the FDA, on behalf of the Minnesota Medical Device Alliance (MMDA). See: http://medgroup.biz/FDA-petition

The petition challenges the FDA's practices and interpretations for reviewing 510(k)s and asks the Commissioner to stay the implementation of “Draft Guidance: Evaluating Substantial Equivalence in Premarket Notifications [510(k)],” dated December 27, 2011. It seeks reversion to older guidance until FDA addresses:

Its practice of “stage-gating” reviews (because it leads to an inevitable FDA request to pursue the de novo path); Its interpretation of “general versus specific intended use,” now applied so narrowly that FDA considers almost every new indication for a 510(k) device to be a new intended use; Its interpretation of clinical utility/benefit as part of the substantial equivalence (SE) criteria (because it essentially allows FDA to determine which devices practitioners should use); Its inappropriate use of statutes and regulatory matters extraneous to the SE decision (e.g., cGMP/Quality Systems, MDR, FD&C Act advertising and promotion, and OSHA regulations or CDC guidance); Its application of risk mitigation and “assurance case” principles to 510(k) clearance criteria; Its interpretation when a device has a new technological characteristic which raises new questions of safety and effectiveness; Its failure in stage-gated reviews to review performance data to determine same intended use / technological characteristics and if new safety and effectiveness questions need to be asked; Its practice of dictating the non-clinical and clinical performance data an applicant must generate (instead of reviewing submitted data at face value for an SE decision); and, Its approach to “whistleblowing,” which can lead to risk-averseness for political, not safety, reasons.

 

The petition seems on the mark. Medical device companies are under enormous financial pressures with difficult economies both domestically and abroad. Add to this the 2.3% medical device tax on gross revenues and a highly bureaucratic, overbearing (if you agree with this petition) FDA and you can’t help but envision difficult times ahead for our industry. Innovative small and midsize companies are struggling, and the government and the FDA aren’t helping matters by treating innovation as the problem. Many on the device side seem unable or unwilling to challenge the FDA bureaucracy.  Win the battle but lose the war, perhaps? As one CEO recently shared, "Challenging [the FDA] might make me feel better but it won't resolve the problem." A real shame as, according to this petition, the FDA and some of its policies need to be challenged.

I agree with this petition that the United States may fall behind other countries in having access to state-of-the-art medical devices while they still are state-of-the-art. That ship may have already sailed, in fact. I also agree that innovation – something we have always embraced and encouraged as a great nation – is being thwarted rather than supported. Healthcare consumers and innovative device companies are suffering and will continue to do so if changes aren’t made. 

Despite said doom and gloom, some innovative, well-managed companies will blast through the aforementioned roadblocks and become stronger, particularly as competition drops off. But I’m concerned that it's going to be mostly the largest companies that survive, and innovation might not always be their strongest suit. I’m also concerned that, as competition disappears, medical device prices will increase – not good for consumers or our Healthcare System.

There is a symbiotic relationship between healthcare providers, healthcare consumers, device manufacturers, our government and the FDA. Sadly, the later have too much power and our system, as this petition suggests, is out of balance and in need of correction. If you agree, beat the drums!

Related Content

Find Your Heart a Home, ACC, cardiac care hospital, comparison database, MedStar Heart & Vascular Institute
News | Patient Engagement| February 08, 2016
MedStar Heart & Vascular Institute at MedStar Washington Hospital Center is one of two hospitals in the nation...
Stanford Health Care, MyHealth mobile app, Android
News | Patient Engagement| February 03, 2016
Stanford Health Care recently released a new app that allows patients using Android smartphones to easily access their...
Agfa Healthcare, HIMSS16, enterprise imaging, ECM, Portal
News | Enterprise Imaging| February 02, 2016
Agfa HealthCare announced it would be showcasing its convergence approach to enterprise imaging during the 2016...
American Heart Association, IBM Watson Health, Welltok, workplace heart health

American Heart Association Chief Medical Officer for Prevention Eduardo Sanchez, MD, MPH, checks out Welltok's health optimization app, which will serve as the platform for a new workplace health program in a new collaboration between AHA, IBM Watson Health and Welltok.

Technology | Patient Engagement| February 01, 2016
On February 1, the first day of American Heart Month, the American Heart Association (AHA) announced plans to develop a...
Technology | Information Technology| January 28, 2016
Boston Scientific Corp. and Accenture have developed a cloud-based, data-driven digital health solution for hospitals...
integrated clinical decision support, CDS, Wolters Kluwer, E-book
News | Clinical Decision Support| January 28, 2016
The Health division of Wolters Kluwer announced the release of a complimentary e-book that demonstrates the critical...
CMS, Meaningful Use replacement, Meaningful Outcomes, JPM16
News | Electronic Medical Records (EMR)| January 15, 2016
The Centers for Medicare and Medicaid Services (CMS) announced Monday that it will be ending the Meaningful Use program...
AMA, Health2047, healthcare innovation company, Silicon Valley
News | Information Technology| January 13, 2016
The American Medical Association (AMA) announced that it is investing $15M to become founding partner of a healthcare...

Image courtesy of Philips Healthcare

Feature | Clinical Decision Support| January 06, 2016 | Dave Fornell
News | Information Technology| December 29, 2015
December 29, 2015 — The Healthcare Information and Management Systems Society (HIMSS) applauded the U.S.
Overlay Init